HNL Genomics (CTGT) now participates with health insurance providers but cannot guarantee that any particular provider will reimburse you or HNL Genomics (CTGT) for our testing services.

In order to better serve our clients, HNL Genomics (CTGT) offers benefit investigation and prior authorization services. The benefit investigation process will help determine the patient’s coverage and if prior authorization is required for testing. It will also determine the patient’s cost for testing.

If prior authorization is required, HNL Genomics (CTGT) will work to submit the request on behalf of the provider and patient so that testing can be authorized, performed, and reimbursed without significant delay.

In order to provide all necessary information to the insurance company for both benefit investigation and prior authorization the Prior Authorization Information packet must be completed and submitted to HNL Genomics (CTGT) via fax 484-244-2904 or secure email to . Please be reminded not to send patient information via unencrypted email as email is inherently unsecure.

For general questions on benefit investigation and prior authorization or to verify that HNL Genomics (CTGT)  participates with your insurance provider please contact our billing experts at 844-465-2455 option 4 or contact your insurance company directly.

The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. HNL Lab Medicine strongly recommends confirmation of CPT codes with third-party payors and/or the AMA. We assume no responsibility for billing errors due to reliance upon CPT codes provided by HNL Lab Medicine.


October 28, 2022

Non-Hodgkin Lymphoma FISH Panel Now Available

B-cell lymphoma is a large group of heterogenous disorders and comprises a majority of non-Hodgkin lymphomas.
Read More
October 20, 2022

Genetic testing for Familial Transthyretin Amyloidosis (TTR) NOW AVAILABLE In-House

Hereditary amyloidosis is a life-threatening disorder that can lead to peripheral neuropathy and heart failure.
Read More
August 08, 2022

Familial hypercholesterolemia (FH)

Familial hypercholesterolemia (FH) is a genetic disorder that increases the likelihood of having coronary heart disease at a younger age. Learn about how to determine if you have hypercholesterolemia and what actions you can take to create better outcomes!

Read More
April 11, 2022

Genome Sequencing: A Vital Tool Used in Identifying and Tracking New COVID-19 Variants

Genome sequencing is reading or decoding the complete genetic information i.e. “Genome” of an organism that is encrypted in the form of a very long string called DNA made up of 4 letters, A, T, G, and C. The genome of an organism essentially determines their physical characteristics and ...
Read More
March 03, 2022

The Effect of Genetics on Individual Heart Health: Early Identification of FH Variations to Optimize Treatment

Test must be ordered by a Physician.

Familial hypercholesterolemia (FH) is a genetic disorder that is characterized by abnormally high blood levels of low-density lipoprotein (LDL) cholesterol, sometimes referred to as "bad cholesterol". This condition affects an estimated 1 in 250 people, and increases the likelihood of developing cardiovascular disease. In fact, FH is estimated to be the cause of 2-3% of heart attacks in individuals younger than age 60.

Read More